Beta-adrenergic cardiac hypertrophy is mediated primarily by the beta(1)-subtype in the rat heart.
about
Endocytosis machinery is required for beta1-adrenergic receptor-induced hypertrophy in neonatal rat cardiac myocytesHistone deacetylases facilitate sodium/calcium exchanger up-regulation in adult cardiomyocytesIn Vivo Phosphoproteomics Analysis Reveals the Cardiac Targets of -Adrenergic Receptor SignalingKMUP-1 attenuates isoprenaline-induced cardiac hypertrophy in rats through NO/cGMP/PKG and ERK1/2/calcineurin A pathwaysβ-Adrenergic receptor-PI3K signaling crosstalk in mouse heart: elucidation of immediate downstream signaling cascades.Beta-adrenergic signaling in the heart: dual coupling of the beta2-adrenergic receptor to G(s) and G(i) proteins.β-Adrenergic receptor stimulation and activation of protein kinase A protect against α1-adrenergic-mediated phosphorylation of protein kinase D and histone deacetylase 5Inhibition of Na+/H+-exchanger with sabiporide attenuates the downregulation and uncoupling of the myocardial beta-adrenoceptor system in failing rabbit hearts.Isoproterenol induces vascular oxidative stress and endothelial dysfunction via a Giα-coupled β2-adrenoceptor signaling pathwaySympathetic nervous system activity and ventricular tachyarrhythmias: recent advances.Cardiac implications for the use of beta2-adrenoceptor agonists for the management of muscle wasting.Protein kinase D3 is a pivotal activator of pathological cardiac hypertrophy by selectively increasing the expression of hypertrophic transcription factors.Intracoronary Cytoprotective Gene Therapy: A Study of VEGF-B167 in a Pre-Clinical Animal Model of Dilated CardiomyopathyNicotinic Acid Adenine Dinucleotide Phosphate (NAADP) and Cyclic ADP-Ribose (cADPR) Mediate Ca2+ Signaling in Cardiac Hypertrophy Induced by β-Adrenergic Stimulation.Activation of AP-1 contributes to the beta-adrenoceptor-mediated myocardial induction of interleukin-6.Neurohumoral activation in heart failure: the role of adrenergic receptors.Beta3-adrenoreceptor stimulation ameliorates myocardial ischemia-reperfusion injury via endothelial nitric oxide synthase and neuronal nitric oxide synthase activation.β-Adrenergic regulation of cardiac progenitor cell death versus survival and proliferation.Beta-adrenergic pathways in human heart failure.beta3-adrenergic receptor activation increases human atrial tissue contractility and stimulates the L-type Ca2+ currentModulation of beta-adrenergic receptor signaling in heart failure and longevity: targeting adenylyl cyclase type 5.Mitochondria in cardiac hypertrophy and heart failure.CaMKII in the cardiovascular system: sensing redox states.Targeting cardiac β-adrenergic signaling via GRK2 inhibition for heart failure therapyThe role of catecholamines in mesenchymal stem cell fate.beta-Adrenergic receptor stimulated Ncx1 upregulation is mediated via a CaMKII/AP-1 signaling pathway in adult cardiomyocytes.β2 adrenergic activation induces the expression of IL-18 binding protein, a potent inhibitor of isoproterenol induced cardiomyocyte hypertrophy in vitro and myocardial hypertrophy in vivo.Interleukin-18 is a pro-hypertrophic cytokine that acts through a phosphatidylinositol 3-kinase-phosphoinositide-dependent kinase-1-Akt-GATA4 signaling pathway in cardiomyocytes.Profiling of cardiac β-adrenoceptor subtypes in the cardiac left ventricle of rats with metabolic syndrome: Comparison with streptozotocin-induced diabetic rats.PEG-coated gold nanoparticles attenuate β-adrenergic receptor-mediated cardiac hypertrophy.Regulation of cardiac stress signaling by protein kinase d1.Inhibition of p38 alpha MAPK rescues cardiomyopathy induced by overexpressed beta 2-adrenergic receptor, but not beta 1-adrenergic receptor.Non-neuronal cholinergic machinery present in cardiomyocytes offsets hypertrophic signalsGlycogen synthase kinase 3beta regulates GATA4 in cardiac myocytes.Strain-dependent beta-adrenergic receptor function influences myocardial responses to isoproterenol stimulation in mice.Effect of sodium houttuyfonate on myocardial hypertrophy in mice and rats.Comparison of isoproterenol and dobutamine in the induction of cardiac hypertrophy and fibrosis.The gp130/STAT3 signaling pathway mediates beta-adrenergic receptor-induced atrial natriuretic factor expression in cardiomyocytes.A beta1-adrenergic receptor CaM kinase II-dependent pathway mediates cardiac myocyte fetal gene induction.Investigating β-adrenergic-induced cardiac hypertrophy through computational approach: classical and non-classical pathways.
P2860
Q28578076-14F0BDBE-7837-4C61-A0D2-D447E0564E8AQ28582424-5D61402F-5240-4E3C-844B-BAC505E16119Q30002317-FB686207-C154-448E-8D87-9EDAC2264538Q33730630-60BAD475-68CA-4B03-9342-7475DF5C1C6EQ34058699-B4ABFC1D-4CB2-4BB1-A1A9-F43286733EADQ34403963-D5825B89-7F67-483F-B4CF-15CA138212D5Q35083061-64B40C3F-37B3-4FBE-BC75-77039F631D1DQ35100887-E8D7DA1B-4B34-413C-8513-105184A2D43DQ35119132-0D9676EC-F856-491A-BB01-23A4AFA1435DQ35171874-D8F7BAAA-FAEB-43A7-AF85-4F1BD8A26FF0Q35545370-18F7CB7A-278B-4D80-A47C-304581059073Q35562514-863EDC5A-4CAB-4FDF-8E80-AE4AD07F3BA5Q35844633-DFA3C01C-B26E-4DC0-9E54-8BB235B0260CQ35950983-E6CD6802-EB5C-41E8-B55C-653ECED3F31FQ36072891-4B2FF1E9-A3CB-4809-B95D-531DD7F3825FQ36579463-7C89B06B-3DA6-4B6F-AE49-897F55FB4CF3Q36652837-37055BBE-F435-468E-A5CE-29C1FF3C3EDEQ36677020-3CE624D9-3BBA-4DE9-AFC3-9FEE839C802EQ36691656-8B4F9DB6-043E-4067-82C9-68006678E419Q36835728-D597AB4D-AD9E-4A0B-BEF9-F83AC7B56C3EQ36848480-AD51ECF4-E80F-470F-B843-A9FAEF848632Q37246892-FB6201E0-1B55-4E5D-98CC-51F1AD8CC7F7Q37899670-A2552E62-7941-414E-9654-23F9EB88E6B7Q38153376-B7E7298F-D86F-40D8-9999-6776E78A723CQ38244904-8BE7FAD3-94FE-4C68-AD36-18CDDE0B5C37Q39810592-AA07EFBA-2DFD-4145-9A24-7109A5FF0A85Q39992588-9EDCC41E-FFA8-484F-9629-BBD014B94921Q40485863-AB7B3E67-76D0-43AD-BD74-AE33E0D172C4Q40918549-83348F2C-0DC0-41F9-BB16-7F4CEB12985AQ40970624-1945B0A0-80DC-4B58-BD24-4B01CD8CED4BQ41496270-7ACD5EB9-E22A-4CC3-8BF9-9A12BEACA01BQ41954132-C69A1C99-B783-4F94-8459-CA003A057C3DQ42248727-4337E61E-EFA6-42D3-B5D3-F0A896770DB7Q42505146-413D7669-5E9A-489B-B9AB-D293830634E4Q45304589-04EF6425-E971-48F8-83AE-E667AF6A913AQ46030422-6ECC02CF-46C2-4E16-9E90-E7527E808845Q46139389-909B90A5-4DD0-4467-BCCA-8AD778F971F2Q46553059-17AA07D6-FF55-41B1-A9D4-6B4E8E54E8B6Q46963117-049A0E78-D4B4-4C4E-A512-AC85D59762F2Q47961540-BEF7A8ED-8E55-4AFC-9DDE-CAAE7739CD89
P2860
Beta-adrenergic cardiac hypertrophy is mediated primarily by the beta(1)-subtype in the rat heart.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Beta-adrenergic cardiac hypert ...... a(1)-subtype in the rat heart.
@ast
Beta-adrenergic cardiac hypert ...... a(1)-subtype in the rat heart.
@en
type
label
Beta-adrenergic cardiac hypert ...... a(1)-subtype in the rat heart.
@ast
Beta-adrenergic cardiac hypert ...... a(1)-subtype in the rat heart.
@en
prefLabel
Beta-adrenergic cardiac hypert ...... a(1)-subtype in the rat heart.
@ast
Beta-adrenergic cardiac hypert ...... a(1)-subtype in the rat heart.
@en
P2093
P356
P1476
Beta-adrenergic cardiac hypert ...... ta(1)-subtype in the rat heart
@en
P2093
Zebrowski DC
P304
P356
10.1006/JMCC.2000.1332
P577
2001-03-01T00:00:00Z